NO905172L - Aminokarbonylkarbamater beslektet med fysostigmin og fremgangsmaate for fremstilling derav. - Google Patents

Aminokarbonylkarbamater beslektet med fysostigmin og fremgangsmaate for fremstilling derav.

Info

Publication number
NO905172L
NO905172L NO90905172A NO905172A NO905172L NO 905172 L NO905172 L NO 905172L NO 90905172 A NO90905172 A NO 90905172A NO 905172 A NO905172 A NO 905172A NO 905172 L NO905172 L NO 905172L
Authority
NO
Norway
Prior art keywords
loweralkyl
physostigmin
aminocarbonyl
procedures
preparing
Prior art date
Application number
NO90905172A
Other languages
English (en)
Other versions
NO175310C (no
NO905172D0 (no
NO175310B (no
Inventor
Edward Joseph Glamkowski
Yulin Chiang
Russell Richard Lee Hamer
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO905172D0 publication Critical patent/NO905172D0/no
Publication of NO905172L publication Critical patent/NO905172L/no
Publication of NO175310B publication Critical patent/NO175310B/no
Publication of NO175310C publication Critical patent/NO175310C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO905172A 1989-11-30 1990-11-29 Analogifremgangsmåte til fremstilling av terapeutisk aktive pyrrolo(2,3-b)indolderivater NO175310C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/443,682 US5077289A (en) 1989-11-30 1989-11-30 Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Publications (4)

Publication Number Publication Date
NO905172D0 NO905172D0 (no) 1990-11-29
NO905172L true NO905172L (no) 1991-05-31
NO175310B NO175310B (no) 1994-06-20
NO175310C NO175310C (no) 1994-09-28

Family

ID=23761787

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905172A NO175310C (no) 1989-11-30 1990-11-29 Analogifremgangsmåte til fremstilling av terapeutisk aktive pyrrolo(2,3-b)indolderivater

Country Status (23)

Country Link
US (1) US5077289A (no)
EP (1) EP0430201B1 (no)
JP (1) JPH0723378B2 (no)
KR (1) KR100215346B1 (no)
AT (1) ATE143020T1 (no)
AU (1) AU626740B2 (no)
CA (1) CA2031079C (no)
CZ (1) CZ280888B6 (no)
DE (1) DE69028605T2 (no)
DK (1) DK0430201T3 (no)
ES (1) ES2094742T3 (no)
FI (1) FI93451C (no)
GR (1) GR3021210T3 (no)
HU (1) HU207321B (no)
IE (1) IE75716B1 (no)
IL (1) IL96498A (no)
NO (1) NO175310C (no)
NZ (1) NZ236248A (no)
PL (1) PL165775B1 (no)
PT (1) PT96030B (no)
RU (1) RU2069664C1 (no)
YU (1) YU224790A (no)
ZA (1) ZA909590B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
US5173497A (en) * 1990-05-17 1992-12-22 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
NZ248180A (en) * 1992-07-21 1995-02-24 Hoechst Roussel Pharma Process for the preparation of physostigmine carbamate derivatives
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US6495700B1 (en) 2002-01-09 2002-12-17 Axonyx, Inc. Process for producing phenserine and its analog
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
WO2005123068A2 (en) * 2004-06-08 2005-12-29 Axonyx, Inc. Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor
WO2006004201A1 (ja) * 2004-07-01 2006-01-12 Eisai R & D Management Co., Ltd. 神経再生促進剤
TWI655179B (zh) * 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4765985A (en) * 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US4900748A (en) * 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use

Also Published As

Publication number Publication date
DK0430201T3 (no) 1997-06-16
US5077289A (en) 1991-12-31
ES2094742T3 (es) 1997-02-01
EP0430201A3 (en) 1992-01-02
RU2069664C1 (ru) 1996-11-27
CA2031079C (en) 2001-01-23
FI93451C (fi) 1995-04-10
FI93451B (fi) 1994-12-30
NO175310C (no) 1994-09-28
PL288016A1 (en) 1992-06-26
EP0430201B1 (en) 1996-09-18
ATE143020T1 (de) 1996-10-15
CZ594890A3 (en) 1995-02-15
DE69028605D1 (de) 1996-10-24
JPH0723378B2 (ja) 1995-03-15
PL165775B1 (pl) 1995-02-28
NO905172D0 (no) 1990-11-29
EP0430201A2 (en) 1991-06-05
GR3021210T3 (en) 1996-12-31
YU224790A (sh) 1993-10-20
NO175310B (no) 1994-06-20
KR100215346B1 (ko) 1999-08-16
ZA909590B (en) 1991-09-25
KR910009707A (ko) 1991-06-28
CA2031079A1 (en) 1991-05-31
DE69028605T2 (de) 1997-03-06
PT96030B (pt) 1998-01-30
NZ236248A (en) 1993-02-25
IE904308A1 (en) 1991-06-05
FI905855A0 (fi) 1990-11-28
IE75716B1 (en) 1997-09-24
HU908014D0 (en) 1991-06-28
IL96498A0 (en) 1991-08-16
HU207321B (en) 1993-03-29
HUT57773A (en) 1991-12-30
JPH03181483A (ja) 1991-08-07
AU6708590A (en) 1991-06-06
IL96498A (en) 1994-08-26
FI905855A (fi) 1991-05-31
PT96030A (pt) 1991-09-13
AU626740B2 (en) 1992-08-06
CZ280888B6 (cs) 1996-05-15

Similar Documents

Publication Publication Date Title
NO905172D0 (no) Aminokarbonylkarbamater beslektet med fysostigmin og fremgangsmaate for fremstilling derav.
NO903851L (no) Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter.
FI893467A (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
CA2029265A1 (en) 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
NO174549C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, asymmetrisk substituerte, heterocykliske forbindelser
DK0402752T3 (da) N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO901385L (no) Karbonatderivater av eserolin, fremgangsmaate for fremstilling derav og deres anvendelse som medikamenter.
IL99434A0 (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and pharmaceutical compositions containing them
HUT40658A (en) Process for producing benzo/c/-1,5-naphtiridin derivatives and pharmaceutical compositions containing them as active agents
DK259388D0 (da) 1-(n-(2-alkylthio-10h-phenothiazin-10-yl)alkyl)-4-benzoylpiperidiner, deres fremstilling og anvendelse
PT98646A (pt) Processo para a preparacao de carbamoil-1-(piridinalquil)-1h-indois indolinas e os seus analogos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2001